Case Study | October 02, 2008 | W. Dennis Foley, M.D., professor of radi

In this retrospectively gated full thoracic CT study, the examination was performed using the LightSpeed VCT 64 system with 0.625 mm detector collimation, retrospective cardiac gating and mono-sector reconstruction. The patient received three 5 mg injections of Metoprolol intravenously for cardiac rate control. Heart rate during acquisition was 64 to 65 BPM.

All bypass grafts (Figures 2 and 3) are normally patent. Curved planar reformations and thin-section MIPs document patency of the arterial and venous bypass grafts, the appearance at the implant site and the native distal coronary circulation.
There is extensive proximal coronary artery calcification and an indeterminate degree of proximal stenosis/occlusion in the major coronary arteries.

An incidental finding is a distal submucosal esophageal lesion, a probable leiomyoma.


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now